1.Application study of auricular Gua Sha in patients with chronic renal failure accompanied by nausea and vomiting
Lijuan AI ; Shushu LU ; Jianjian SHI ; Jifen SHI ; Jing YE
Chinese Journal of Nursing 2025;60(12):1434-1439
Objective To explore the effectiveness of auricular Gua Sha based on auricular vagus nerve stimulation in patients with chronic renal failure accompanied by nausea and vomiting.Methods Using a convenience sampling method,100 patients with chronic renal failure and nausea and vomiting admitted to the Nephrology Department of a tertiary hospital in Zhejiang Province between January 2022 and December 2023 were selected.They were randomly divided into a test group and a control group,with 50 patients in each group.The test group received the conventional treatment and care for chronic renal failure with nausea and vomiting,along with auricular Gua Sha,with a 3-day intervention.The control group received only conventional treatment and care.The Traditional Chinese Medicine(TCM)symptom scores for nausea and vomiting,total effective rate of the efficacy index,symptom improvement time,total number of bowel movements,and adverse events were compared between the 2 groups.Results A total of 100 patients completed the study.After intervention,the scores for nausea and vomiting symptoms were lower in both groups compared to the scores before intervention,with the experimental group having lower scores than the control group(P<0.001);the total effective rate of the experimental group was 98.00%,higher than 88.00%in the control group(P<0.001).Following intervention,the time for improvement of nausea and vomiting symptoms in the experimental group was(7.50±1.74)minutes,shorter than(13.38±2.31)minutes in the control group(P<0.001);the total number of bowel movements in the experimental group was(3.34±0.63)times,more than(2.46±0.58)times in the control group(P<0.001);no adverse events occurred during the study.Conclusion Auricular Gua Sha based on auricular vagus nerve stimulation helps reduce nausea and vomiting symptom scores,improves the total effective rate of the efficacy index,shortens the symptom improvement time,increases the frequency of bowel movements,and it is safe for patients with chronic renal failure.
2.Efficacy and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome
Shiqiang QU ; Ningning LIU ; Tiejun QIN ; Zefeng XU ; Bing LI ; Lijuan PAN ; Meng JIAO ; Qingyan GAO ; Huijun WANG ; Xiaofei AI ; Zhijian XIAO
Chinese Journal of Hematology 2025;46(7):611-617
Objective:To analyze the clinical characteristics, therapeutic responses, and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome (L-HES) .Methods:We retrospectively reviewed clinical data from 16 consecutive patients diagnosed with L-HES at the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, between July 2019 and October 2024. A control group of 65 patients with idiopathic hypereosinophilic syndrome (iHES), diagnosed during the same period, was used for comparison. Clinical and laboratory characteristics, therapeutic responses, and survival outcomes were compared between the two groups.Results:The most frequently involved organs at presentation in patients with L-HES were the skin (75.0%), gastrointestinal tract (25.0%), respiratory tract (18.8%), lymph nodes (18.8%), heart (12.5%), and spleen (6.3%). Compared with iHES patients, patients with L-HES had a significantly higher incidence of skin involvement ( P=0.016), with no statistically significant differences observed in the involvement of other organs. No statistically significant differences were found in complete blood count parameters between the two groups. Multiparameter flow cytometry revealed that the median percentage of CD3 -CD4 + T cells in the peripheral blood of patients with L-HES was 4.08% ( IQR: 1.64%-32.78%), with a median absolute count of 0.10 (0.05-0.55) ×10 9/L. Serum immunoglobulin E (IgE) levels were significantly higher in the L-HES group than in the iHES group ( P<0.001). Clonal rearrangement of T-cell receptor genes was detected in 75.0% of patients with L-HES. After diagnosis, 14 patients with L-HES received glucocorticoids as first-line therapy, yielding an overall response rate of 92.9%. During glucocorticoid tapering, 11 patients experienced recurrent eosinophilia or worsening of clinical symptoms. Three patients received interferon-alpha as a second-line therapy, with two achieving complete remission. After a median follow-up of 16 months ( IQR: 8-28 months), one patient died of cardiac insufficiency 8 months after diagnosis, and no cases of lymphoma transformation were observed. The 2-year overall survival rate was (91.7±8.0) %, which did not significantly differ from that of the iHES group (96.2±2.6) % ( P=0.746) . Conclusions:Patients with L-HES generally have a favorable prognosis and are often characterized by skin involvement and significantly elevated serum IgE levels at diagnosis. They typically respond well to glucocorticoid therapy, although relapse is common during dose tapering. Interferon-alpha may serve as an effective second-line therapeutic option.
3.Applications of PET molecular imaging in diagnosis and treatment of Alzheimer's disease
Liping FU ; Lijuan YU ; Jun ZHAO ; Lin AI
Chinese Journal of Medical Imaging Technology 2025;41(8):1372-1377
PET of molecular imaging plays a pivotal role in Alzheimer's disease(AD)by visualizing and quantifying amyloid β(Aβ)deposition,phosphorylated tau protein(T)and glucose metabolism,having important value in the entire process of diagnosis and treatment of AD.The applications of PET multimodal imaging in AD were systematically reviewed in this article,in order to advance precision diagnosis,treatment and scientific management of AD.
4.Application study of auricular Gua Sha in patients with chronic renal failure accompanied by nausea and vomiting
Lijuan AI ; Shushu LU ; Jianjian SHI ; Jifen SHI ; Jing YE
Chinese Journal of Nursing 2025;60(12):1434-1439
Objective To explore the effectiveness of auricular Gua Sha based on auricular vagus nerve stimulation in patients with chronic renal failure accompanied by nausea and vomiting.Methods Using a convenience sampling method,100 patients with chronic renal failure and nausea and vomiting admitted to the Nephrology Department of a tertiary hospital in Zhejiang Province between January 2022 and December 2023 were selected.They were randomly divided into a test group and a control group,with 50 patients in each group.The test group received the conventional treatment and care for chronic renal failure with nausea and vomiting,along with auricular Gua Sha,with a 3-day intervention.The control group received only conventional treatment and care.The Traditional Chinese Medicine(TCM)symptom scores for nausea and vomiting,total effective rate of the efficacy index,symptom improvement time,total number of bowel movements,and adverse events were compared between the 2 groups.Results A total of 100 patients completed the study.After intervention,the scores for nausea and vomiting symptoms were lower in both groups compared to the scores before intervention,with the experimental group having lower scores than the control group(P<0.001);the total effective rate of the experimental group was 98.00%,higher than 88.00%in the control group(P<0.001).Following intervention,the time for improvement of nausea and vomiting symptoms in the experimental group was(7.50±1.74)minutes,shorter than(13.38±2.31)minutes in the control group(P<0.001);the total number of bowel movements in the experimental group was(3.34±0.63)times,more than(2.46±0.58)times in the control group(P<0.001);no adverse events occurred during the study.Conclusion Auricular Gua Sha based on auricular vagus nerve stimulation helps reduce nausea and vomiting symptom scores,improves the total effective rate of the efficacy index,shortens the symptom improvement time,increases the frequency of bowel movements,and it is safe for patients with chronic renal failure.
5.Efficacy and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome
Shiqiang QU ; Ningning LIU ; Tiejun QIN ; Zefeng XU ; Bing LI ; Lijuan PAN ; Meng JIAO ; Qingyan GAO ; Huijun WANG ; Xiaofei AI ; Zhijian XIAO
Chinese Journal of Hematology 2025;46(7):611-617
Objective:To analyze the clinical characteristics, therapeutic responses, and survival outcomes of patients with lymphocytic variant hypereosinophilic syndrome (L-HES) .Methods:We retrospectively reviewed clinical data from 16 consecutive patients diagnosed with L-HES at the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, between July 2019 and October 2024. A control group of 65 patients with idiopathic hypereosinophilic syndrome (iHES), diagnosed during the same period, was used for comparison. Clinical and laboratory characteristics, therapeutic responses, and survival outcomes were compared between the two groups.Results:The most frequently involved organs at presentation in patients with L-HES were the skin (75.0%), gastrointestinal tract (25.0%), respiratory tract (18.8%), lymph nodes (18.8%), heart (12.5%), and spleen (6.3%). Compared with iHES patients, patients with L-HES had a significantly higher incidence of skin involvement ( P=0.016), with no statistically significant differences observed in the involvement of other organs. No statistically significant differences were found in complete blood count parameters between the two groups. Multiparameter flow cytometry revealed that the median percentage of CD3 -CD4 + T cells in the peripheral blood of patients with L-HES was 4.08% ( IQR: 1.64%-32.78%), with a median absolute count of 0.10 (0.05-0.55) ×10 9/L. Serum immunoglobulin E (IgE) levels were significantly higher in the L-HES group than in the iHES group ( P<0.001). Clonal rearrangement of T-cell receptor genes was detected in 75.0% of patients with L-HES. After diagnosis, 14 patients with L-HES received glucocorticoids as first-line therapy, yielding an overall response rate of 92.9%. During glucocorticoid tapering, 11 patients experienced recurrent eosinophilia or worsening of clinical symptoms. Three patients received interferon-alpha as a second-line therapy, with two achieving complete remission. After a median follow-up of 16 months ( IQR: 8-28 months), one patient died of cardiac insufficiency 8 months after diagnosis, and no cases of lymphoma transformation were observed. The 2-year overall survival rate was (91.7±8.0) %, which did not significantly differ from that of the iHES group (96.2±2.6) % ( P=0.746) . Conclusions:Patients with L-HES generally have a favorable prognosis and are often characterized by skin involvement and significantly elevated serum IgE levels at diagnosis. They typically respond well to glucocorticoid therapy, although relapse is common during dose tapering. Interferon-alpha may serve as an effective second-line therapeutic option.
6.Applications of PET molecular imaging in diagnosis and treatment of Alzheimer's disease
Liping FU ; Lijuan YU ; Jun ZHAO ; Lin AI
Chinese Journal of Medical Imaging Technology 2025;41(8):1372-1377
PET of molecular imaging plays a pivotal role in Alzheimer's disease(AD)by visualizing and quantifying amyloid β(Aβ)deposition,phosphorylated tau protein(T)and glucose metabolism,having important value in the entire process of diagnosis and treatment of AD.The applications of PET multimodal imaging in AD were systematically reviewed in this article,in order to advance precision diagnosis,treatment and scientific management of AD.
7.Analysis of a patient with severe Hemophilia A due to a large duplication of F8 gene.
Wen WANG ; Dongyan CUI ; Lijuan JIANG ; Ai ZHANG ; Aiguo LIU ; Qun HU
Chinese Journal of Medical Genetics 2022;39(1):72-75
OBJECTIVE:
To report on a case with severe hemophilia A (HA) due to a large duplication of F8 gene.
METHODS:
Inversion detection, Sanger sequencing, and multiplex ligation-dependent probe amplification (MLPA) were used to detect the mutation in the proband and his mother.
RESULTS:
The patient, a 7-year-old boy, was diagnosed with severe HA at 8 months. No inhibitor was developed over 150 exposure days. Intronic inversion detection and Sanger sequencing have failed to identify pathogenic variants, while MLPA revealed a large duplication [Ex 1_22 dup (2 copies)] in the proband, for which his mother was a carrier [Ex 1_22 dup (3 copies)]. Large duplications of the F8 gene have so far been found in 24 HA patients, all of whom had a severe phenotype, only one had a history of inhibitors.
CONCLUSION
Large duplications of F8 gene are associated with severe HA. The diagnostic rate for HA may be increased by MLPA.
Child
;
Factor VIII/genetics*
;
Gene Duplication
;
Hemophilia A/genetics*
;
Humans
;
Introns
;
Male
;
Mutation
;
Phenotype
8. Efficacy of massage combined with microwave therapy in treating Children's bronchial pneumonia with syndrome of deficiency of lung-spleen Qi
Lichao WANG ; Donghui ZHANG ; Lijuan CHEN ; Zhiping WANG ; Tuo WANG ; Jianli GUO ; Lei YU
International Journal of Traditional Chinese Medicine 2019;41(9):931-935
Objective:
To investigate the efficacy of massage combined with microwave therapy in treating Children's bronchial pneumonia with syndrome of deficiency of lung-spleen
9. Targeted sequencing analysis of hyper-eosinophilic syndrome and chronic eosinophilic leukemia
Shiqiang QU ; Tiejun QIN ; Zefeng XU ; Yue ZHANG ; Yujiao JIA ; Xiaofei AI ; Hongli ZHANG ; Liwei FANG ; Naibo HU ; Lijuan PAN ; Bing LI ; Jinqin LIU ; Kun RU ; Zhijian XIAO
Chinese Journal of Hematology 2018;39(6):501-506
Objective:
Analysis of the molecular characteristics of eosinophilia.
Methods:
Targeting sequence to 24 patients with chronic eosinophilic leukemia (CEL) with rearrangement of PDGFRA, PDGFRB, or FGFR1 and 62 patients with hyper-eosinophilic syndrome (HES). Mutation annotation and analysis of amino acid mutation using authoritative databases to speculate on possible pathogenic mutation.
Results:
Thirty-seven kinds of clonal variant were detected from 17 patients with CEL, no recurrent mutation site and hot spot region were found. No pathogenic mutation was detected in 19 patients with PDGFRA rearrangement, but pathogenic mutations of ASXL1, RUNX1 and NRAS were detected from 2 patients with FGFR1 rearrangement who progressed to acute myeloid leukemia and 1 patient with PDGFRB rearrangement who progressed to T lymphoblastic lymphoma, respectively. One hundred and two kinds of clonal abnormalities were detected in 49 patients with HES. The main hot spot mutation regions included: CEBPA Exon1, TET2 Exon3, ASXL1 Exon12, IDH1 Y208C, and FGFR3 L164V. CRRLF2 P224L and PDGFRB R370C point mutations were detected separately in 2 patients with HES who treated with imatinib monotherapy and achieved hematologic remission.
Conclusion
The pathogenesis of CEL with PDGFRA, PDGFRB or FGFR1 rearrangement is usually single, and the progression of the disease may involve other driver mutation. A variety of genes with hot mutation regions may be involved in the pathogenesis of HES, and some mutation sites are sensitive to tyrosine kinase inhibitors.
10.Effect of Electroacupuncture on Expression of Phosphodiesterase 4 and Subtypes in Hippocampus in Rats with Chronic Stress Depression
Quankai JING ; Chaoketu SAIYIN ; Haijiang YAO ; Wei LV ; Youdou AOCUN ; Lijuan YANG ; Juntong LIU ; Zhigang LI
Chinese Journal of Rehabilitation Theory and Practice 2016;22(9):1011-1014
Objective To explore the biological mechanisms of electroacupuncture (EA) for depression. Methods Forty male adult Sprague-Dawley rats were randomly divided into control group (n=8), model group (n=8), EA group (n=8) and fluoxetine group (n=8). Depressive models were established with lonely raising and chronic unpredictable mild stress. They were tested with Open-field Test, and the expression of phosphodiesterase 4 (PDE4)A and PDE4D in hippocampus was detected with RT-PCR. Results The cross and rear scores were significantly lower in the model group than in the control group (P<0.001), while it increased in the EA group and the fluoxetine group (P<0.001). Compared with the model group, the expression of PDE4A and PDE4D decreased in the EA group (P<0.001). Conclusion Electroacupuncture may relieve depression through inhibiting the expression of PDE4A and PDE4D.

Result Analysis
Print
Save
E-mail